Our governance model includes: Prescribing restricted to Dr Nirusha Kumaran and Dr Tasnim Elghandy, both holding valid certification in peptide therapy Quarterly clinical audit of outcomes, adverse events, and adherence Documented discontinuation criteria for every active protocol An active adverse event registry and clinical KPI tracking No prescribing in cases of active malignancy, pregnancy, or severe psychiatric illness This level of institutional rigour is what separates physician-led peptide therapy from the commercially driven, under-regulated alternatives that exist elsewhere in the market
People with these conditions might need shots more often
based on 11 independent studies suggests that using probiotics alone is not sufficient for H
Biomolecules, 10 (11) Chandler, F., Reddy, P
Zhu S, Li Y, Huang Y, Zhang M, Gu X, He Y, Liu H, Ma M, Lu W